Corbett-Helaire, Kizzmekia
1986-present · Contribution: 2014-present
Viral immunologist and vaccinologist
Viral immunology and vaccine design; co-designed the mRNA-1273 (Moderna) COVID-19 vaccine through prefusion-stabilized spike-protein research, and contributed to COVID-19 monoclonal-antibody therapeutics
Portraits are AI-generated interpretations, not photographs.
Quick facts
- Born
- 1986, Hurdle Mills, North Carolina
- Active since
- 2014
- Category
- Science & Medicine
- Best known for
- Co-designing the Moderna COVID-19 vaccine
Impact on the world
Corbett-Helaire's work was central to the global COVID-19 response, helping deliver a vaccine at unprecedented speed and saving countless lives.
An alternative history
What Would the World Look Like Without It?
One contribution. Many possible consequences. No single-person origin story.
Imagine this selected contribution absent, not the person or the entire field. The areas below are reflection prompts related to this discipline, not verified chains of direct dependency.
Sources
- Source lookupFind
Science/AAAS
Exact source links open the cited record. Source lookups help locate legacy references whose original records did not include a direct URL.
3 more sources and references are available to members.
Related visionaries
Onesimus
late 1600s-1700s
Introduced the principle and procedure of variolation (smallpox inoculation) to colonial Boston, deliberately introducing material from a smallpox pustule into a small skin wound to confer immunity, based on a practice long used in West Africa
Ferguson, Angella D.
1925-2026
Pediatric research on sickle cell disease in Black infants; developed a blood test to detect the disease at birth and clinical guidelines for diagnosing/treating it in children; found that daily water intake reduced sickle-cell crises and recommended increased oxygen during surgery
Daly, Marie Maynard
1921-2003
First African American woman to earn a PhD in chemistry in the United States
Green, Hadiyah-Nicole
1981-
Developed laser-activated nanoparticle technology for targeted cancer therapy